Fulcrum Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Sell
1,009
-4,186
-81% -$1.55M 0.04% 314
2026
Q1
$1.48M Buy
5,195
+415
+9% +$136K 0.22% 89
2025
Q4
$1.67M Sell
4,780
-141
-3% -$47.6K 0.46% 53
2025
Q3
$1.59M Sell
4,921
-2,589
-34% -$805K 0.44% 55
2025
Q2
$2.92M Buy
+7,510
New +$3.02M 0.83% 35
2022
Q1
Hold
0
135
2021
Q4
Hold
0
61
2021
Q3
Hold
0
62
2021
Q2
Hold
0
36
2021
Q1
Hold
0
50

Other funds holding ELV

Fulcrum Asset Management's ELV Position: Q2 2026 in Review

Fulcrum Asset Management reduced its Elevance Health (ELV) stake by 81% in Q2 2026, selling an estimated $1.55M and leaving 1,009 shares worth $392K. The position accounts for 0.04% of the portfolio, ranked #314.

Fulcrum Asset Management first reported a position in ELV in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.92M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fulcrum Asset Management held 1,009 shares of Elevance Health worth $392K as of Q2 2026.
  • Fulcrum Asset Management sold 4,186 Elevance Health shares in Q2 2026, an estimated $1.55M.
  • Elevance Health made up 0.04% of Fulcrum Asset Management's portfolio in Q2 2026, its #314 holding.
  • Fulcrum Asset Management first reported a position in Elevance Health in Q2 2025 and has held it in 5 quarters since.
  • Fulcrum Asset Management's Elevance Health position peaked at $2.92M in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.